from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2537c/aroD

LFCtreatmentdescriptionclass of inhibitor

-1.211

Amikacinug/mL Amikacintranslation

-1.547

Cap5-10ug/mL Capreomycintranslation

-2.357

Rox10-50 ug/mL Roxithromycintranslation

-0.157

SM2-5 ug/mL Streptomycintranslation

-2.227

Tet5-10 ug/mL Tetracyclinetranslation

-0.111

Rif0.2-5ug/mL Rifampicintranscription

0.202

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.474

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.887

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.643

CPZ10-50 ug/mL Chlorpromazinerespiration

1.138

Clofazimine10-13 ug/mL Clofaziminerespiration

0.810

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.970

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.572

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.044

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.972

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.007

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.826

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.654

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.355

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.607

KCN5-20 ug/mL Potassium cyaniderespiration

0.467

NaN30.2-2 mM Sodium aziderespiration

0.148

Nigericin50 uM Nigericinrespiration

-0.874

TRC10-150 ug/mL Triclosanrespiration

-0.463

TRZ10-25 ug/mL Thioridazinerespiration

-0.462

Valinomycin0.5-10 uM Valinomycinrespiration

-0.865

ZnSO42 mM ZnSO4respiration

-0.073

menadione6-10 ug/mL Menadionerespiration

0.252

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.187

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.220

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.350

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.381

NRP_1Non-replicating persistence stage 1dosRassociated

0.342

Amp0.2mg/mL AmpicillincellWall

0.268

Cephalexin20-100 ug/mL CephalexincellWall

0.604

Cerulenin0.32-5 ug/mL CerulenincellWall

0.476

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.307

EMB10-20 ug/mL EthambutolcellWall

0.915

Eta12-40 ug/mL EthionamidecellWall

1.050

INH0.2-0.4 ug/mL IsoniazidcellWall

0.220

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.299

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.544

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.206

BZA0.12 mg/mL BenzamidearomaticAmides

-0.309

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.222

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.718

H2O24 mM hydrogen peroxideDNAdamaging

0.102

Levo10 ug/mL LevofloxacinDNAdamaging

-0.492

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.383

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.416

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.000

UVUV-irradiationDNAdamaging

-0.641

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.034

Antimycin12.5-50 ug/mL Antimycin A?

0.621

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.117

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.239

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.551

PA8240.2-2 ug/mL PA-824?

1.617

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.574

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.498

Verapamil50 uM Verapamil?

0.421

mercaptoethanol2 mM 2-Mercaptoethanol?

0.520

methoxatin10-20 ug/mL Methoxatin?